Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.

Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.

Item
http://www.wikidata.org/entity/Q37571975
Intrabodies as neuroprotective therapeuticsIBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CAPhysico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.Cystamine and intrabody co-treatment confers additional benefits in a fly model of Huntington's disease.Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments.Molecular mechanisms and potential therapeutical targets in Huntington's disease.Research and development of next generation of antibody-based therapeuticsImmunopharmacology: utilizing antibodies as ion channel modulators.Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteinsPharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.Gene-based antibody strategies for prion diseases.Recombinant Antibody Fragments for Neurodegenerative Diseases.Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies.Nucleic Acid-Based Therapy Approaches for Huntington's DiseaseA bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
P2860

Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.

Item
http://www.wikidata.org/entity/Q37571975
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.
@en
Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.
@nl
type
label
Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.
@en
Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.
@nl
prefLabel
Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.
@en
Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921